Abstract
摘要
相似文献
1
Dapsone in leprosy.
Trop Doct. 1974 Jul;4(3):140.
2
Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.利福平、氯法齐明和氨苯砜联合多药疗法治疗多菌型麻风病例的评估。
Indian J Lepr. 1984 Jan-Mar;56(1):78-85.
3
Co-incident (simultaneous) dapsone sensitivity and dapsone-resistant leprosy.同时存在的氨苯砜敏感和氨苯砜耐药麻风病。
Int J Lepr Other Mycobact Dis. 1983 Jun;51(2):258-9.
4
5
Primary dapsone-resistant leprosy in Republic of Korea.韩国的原发性氨苯砜耐药麻风病。
Int J Lepr Other Mycobact Dis. 1982 Dec;50(4):510.
6
Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.folP1基因中的二氢蝶酸合酶突变预示着麻风病复发病例对氨苯砜耐药。
Clin Infect Dis. 2006 Jan 15;42(2):238-41. doi: 10.1086/498506. Epub 2005 Dec 12.
7
Drug resistance in Nepali leprosy patients.尼泊尔麻风病患者的耐药性
Int J Lepr Other Mycobact Dis. 1996 Jun;64(2):136-41.
8
[Advances in the chemotherapy of leprosy].[麻风病化疗的进展]
Med Trop (Mars). 1984 Jan-Mar;44(1):17-22.
9
Primary dapsone-resistant leprosy in Cebu, Philippines.
Int J Lepr Other Mycobact Dis. 1981 Dec;49(4):427-30.
10
Prevalence of secondary dapsone resistance in Nepal.
Indian J Lepr. 1984 Oct-Dec;56(4):823-7.
Zotero 插件